ASPERGEN LIMITED

CIN U21001MH2026PLC471158

Public Limited CompanyIncorporated 5 May 2026

ASPERGEN LIMITED is a public limited company incorporated on 5 May 2026 with the Registrar of Companies, Mumbai I. Its CIN is U21001MH2026PLC471158 and it is registered in Mumbai, Maharashtra. Its main business activity is manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc. (NIC 21001). It has an authorised capital of ₹11,00,00,000 and a paid-up capital of ₹1,00,000. Its directors are ANIMESH MOHANLAL JAIN, DINESH RAMNIRANJAN JAIN, NEHA BAGARIA and ANURAG BAGARIA.

Company details

Name
ASPERGEN LIMITED
CIN
U21001MH2026PLC471158
Type
Public Limited Company
Date of incorporation
5 May 2026
Registrar of Companies
ROC Mumbai I
Category
Company limited by shares
Sub-category
Non-government company
Authorised capital
₹11,00,00,000
Paid-up capital
₹1,00,000
Business activity
Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.
NIC code
21001
State
Maharashtra
District
Mumbai

Registered office: Tower A, 1st floor Peninsula Business Park Delisle Road

Directors

  • ANIMESH MOHANLAL JAINDirector
  • DINESH RAMNIRANJAN JAINDirector
  • NEHA BAGARIADirector
  • ANURAG BAGARIADirector

First-year compliance calendar

Due dates worked out from the incorporation date. Check the latest MCA notifications for extensions.

ComplianceDue
First board meetingwithin 30 days of incorporation4 June 2026
Appoint the first auditorby the board, within 30 days4 June 2026
Issue share certificateswithin 60 days of incorporation4 July 2026
Commencement of business (INC-20A)within 180 days, after subscribers pay for their shares1 November 2026
Director KYC (DIR-3 KYC)every year, for each director's DIN30 September 2027
Financial statements (AOC-4) and annual return (MGT-7A / MGT-7)AGM due by 31 December 2027; AOC-4 within 30 days and MGT-7 within 60 days of itafter the first AGM

What the CIN U21001MH2026PLC471158 means

U — listing
Unlisted
21001 — industry (NIC)
Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.
MH — state / ROC code
Maharashtra
2026 — year of incorporation
2026
PLC — ownership
Public Limited Company
471158 — registration number
Serial number at the ROC

Never miss an ROC deadline for your clients

Finexo's practice management software tracks INC-20A, AOC-4, MGT-7, LLP Form 8 and Form 11 for every client company, assigns the work to your team and reminds clients before the due date.

See Finexo for CA firms

More new companies in Mumbai

More companies and LLPs

Is this your CIN?

Search another company

Details from Ministry of Corporate Affairs records, last updated 12 October 2026.